Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.

Smith E, Croca S, Waddington KE, Sofat R, Griffin M, Nicolaides A, Isenberg DA, Torra IP, Rahman A, Jury EC.

Sci Immunol. 2016 Dec 2;1(6). pii: eaah4081. doi: 10.1126/sciimmunol.aah4081.

PMID:
28783690
2.

Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages.

Feig JE, Shang Y, Rotllan N, Vengrenyuk Y, Wu C, Shamir R, Torra IP, Fernandez-Hernando C, Fisher EA, Garabedian MJ.

PLoS One. 2011;6(12):e28534. doi: 10.1371/journal.pone.0028534. Epub 2011 Dec 6.

3.

Development of phosphorylation site-specific antibodies to nuclear receptors.

Torra IP, Staverosky JA, Ha S, Logan SK, Garabedian MJ.

Methods Mol Biol. 2009;505:221-35. doi: 10.1007/978-1-60327-575-0_13.

PMID:
19117148
4.

Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages.

Torra IP, Ismaili N, Feig JE, Xu CF, Cavasotto C, Pancratov R, Rogatsky I, Neubert TA, Fisher EA, Garabedian MJ.

Mol Cell Biol. 2008 Apr;28(8):2626-36. doi: 10.1128/MCB.01575-07. Epub 2008 Feb 4.

5.

Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.

Duez H, Lefebvre B, Poulain P, Torra IP, Percevault F, Luc G, Peters JM, Gonzalez FJ, Gineste R, Helleboid S, Dzavik V, Fruchart JC, Fiévet C, Lefebvre P, Staels B.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):585-91. Epub 2004 Dec 23.

PMID:
15618549
7.

ART-27, an androgen receptor coactivator regulated in prostate development and cancer.

Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK.

J Biol Chem. 2004 Apr 2;279(14):13944-52. Epub 2004 Jan 7.

8.

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.

Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B.

Gastroenterology. 2003 Jun;124(7):1926-40.

PMID:
12806625
9.

The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene.

Barbier O, Villeneuve L, Bocher V, Fontaine C, Torra IP, Duhem C, Kosykh V, Fruchart JC, Guillemette C, Staels B.

J Biol Chem. 2003 Apr 18;278(16):13975-83. Epub 2003 Feb 11.

10.

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.

Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26. Review.

PMID:
12006382
11.

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, Staels B.

J Clin Invest. 2002 Apr;109(7):961-71.

12.

Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.

Jamshidi Y, Montgomery HE, Hense HW, Myerson SG, Torra IP, Staels B, World MJ, Doering A, Erdmann J, Hengstenberg C, Humphries SE, Schunkert H, Flavell DM.

Circulation. 2002 Feb 26;105(8):950-5.

PMID:
11864924
13.

Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.

Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B.

Curr Opin Lipidol. 2001 Jun;12(3):245-54. Review.

PMID:
11353326
14.

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B.

Nat Med. 2001 Jan;7(1):53-8.

PMID:
11135616
15.

Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver.

Torra IP, Tsibulsky V, Delaunay F, Saladin R, Laudet V, Fruchart JC, Kosykh V, Staels B.

Endocrinology. 2000 Oct;141(10):3799-806.

PMID:
11014236
16.

Regulation of lipid and lipoprotein metabolism by PPAR activators.

Gervois P, Torra IP, Fruchart JC, Staels B.

Clin Chem Lab Med. 2000 Jan;38(1):3-11. Review.

PMID:
10774955
17.

A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.

Gervois P, Torra IP, Chinetti G, Grötzinger T, Dubois G, Fruchart JC, Fruchart-Najib J, Leitersdorf E, Staels B.

Mol Endocrinol. 1999 Sep;13(9):1535-49.

PMID:
10478844
18.

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.

Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B.

J Biol Chem. 1998 Oct 2;273(40):25573-80.

19.

Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

Vu-Dac N, Gervois P, Torra IP, Fruchart JC, Kosykh V, Kooistra T, Princen HM, Dallongeville J, Staels B.

J Clin Invest. 1998 Aug 1;102(3):625-32.

20.

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A.

Nature. 1998 Jun 25;393(6687):790-3.

PMID:
9655393

Supplemental Content

Loading ...
Support Center